0
0
CL
0
C
3
(D
'U
0
(D
0
h
0
0
0
0
0
Cr
CD
'TRTC'LY CONFIDENTIAL
ASSUMPTIONS
A FVIEMCH
Thvre -will be no sudden scientific
nolution in the fore-cable
ii) It in uni;kely that thore will be
a single product design solution.
iii) Man -..:i'l continue to ijc
-,-YChODharmacological nids,
inclu,ling cigarettes.
iv) 'Urnok.,ng will b(:ccmc an
increasingly unacrt!ptable ,;ocLal
h fl,
v) Passive smcking will bveome more
iflpo~tant as an issue.
vi) Reduction in biolorLcial activiLy
1. ,
cit, -.LL . (raLher than
p. i ;..
activity) will conLini, to be
Ccept'.:! by -!Octors I.,;
0/ 1/60 1 U
"MOKIMG AND HEALTH
POLICEES
i In pri.nciple to agree that any
iiivuitLion considered by
MI-lbank Qi be of major
to shoul.0
1- o1*t'(-r'-11 to 0111- competiturs on
t,rm., to be grced.
ii) To (Ne diligence by
kj~-Icc.lilll; ~111Y approacilf!S nade to
Group c.-!yanien by doctors or
havin,,, oii[-,gc z; t ions on
;,nd health r(!search.
iii) TO :;-+ -.-Y:; 01, limil'ing Lh'!
of in
nny produot.
PAGE I
GUIDELTNES
No t,?
The following guidelines are act out
ior those Group Companies which are
already having to deal with the
smoking and health issue. lt is
obviously not suggt!sLed that in those
countries, where the issue is not yet
live one, companier~ should bring it
to tho fore by initiating action, but
they should nevcrtheless prepare
themselves to act on the gui(](.-linL,.-;,
ai; appropriate, if and whon the inoue
does become a live one.
i) Research into and development of
new products is the key strategy
to solving the smoking and health
problem. To this end B-A.T.
will work in this field with any
group having the same objectives
in order to further the interests
of its consumers.
ii) B-A.T.'s main research efforts.
aiw,20 at modifying cigarettes
will concentrate on:-
i. cigarette design
ill. rccon,,titution of tobacco
B.Itflake
iv. rubstitute materials
iii) To follow up through 11 & D
DoparLint;nt, MillbfLnk, all
approachcs made to Group member
companies by doctors or
scientists 1-3ving suggestionc- on
~mokinG and health research.
COUT/ ......


0
0
CL
0
-3
CD
M
0
<
5,
C)
M
0
h
0
0
Cr
0
0
r+
0
Cr
CD
CO
to
to
ASSUPWTIONS
A RESEARCH (cont.)
vii) fl.~okijij, during, pregnancy will
becone more important as an issue.
viii) The inrlu~itry will continue to be
('or nponflh,g w,eh
on ad-L-Liuing Lhan 0:1 11COLh
research.
1 M.6010C,
SMOXJNG AND IMALTII
POLTC I 1,'S
PAGE 2
GUIDELINES
iv) To encourage reaearch on the
rusceptible sub group
hypothesis.
v) W!n-a-ch on the perceiv"O
benct'Itr of sinokinG should
be continued.
vi.) Biological activity per cigarette
rather than specific activity
or condensate, is accepted a.; a
basis for work on alternative
smoking materials, both tobacco
and non-tobacco.
vii) The use in product development
of tests relating to physical
properties of smoke should be
strongly encouraged in Group
laboratories.
viii) R & D Department, Hillbank, to
revieif all evidence on Smoking
in PregnF_ncy.
ix) To build up a good reputation
for the Group's scientific
research.
X) In there countries where the
inductry is carrying out or
sponsoring health research, it
should keep the medicul
authorities fully informed and
welcome their collaboration and
views. It should also make
CONT/ ......


0
0
CL
0
(D
M
S
0
CD
0
h
U3
0
0
E,
3
Cr
CAD
0
a
0
Cr
ASSUMPTIONS
A RESEMICH (cant.)
~z 1 Z60 1 H
SMOKING AND HEWAII
POTJ 0 1 F'S
PAGE
GITIDELINFS
X) cant.
known to them the extent of the
research effort in other
countries.
In countries where the local
Lild"Litry liar not yet :-.ponsoi-Ld
research, it should provide the
appropriate health authorities
With information about industry
research in other countries,
as appropriate.


0
0
CL
0
0
CD
0
0
<
CD
0
ED
=r
0
0
-3
Ito
0
!I
0
a
CD
Ito
SMOKTNG AND HEALTH
ASSUMPTIONS POLICIE'S
B IlEfATIOUS WITH GOVERVNINTS, MEDICAL
AUTHORITIES, INDUSTHY A111) THE' MEDIA.
i) The a.,:sociation of t;rloking with i)
various diseases will continue
to a major Lhveat. to the
Lo-;cco industry.
ii) An ind,vll.ry atHl"uh...
ill ch"lle"f-,ine; Lho
viilidii..-y of all the t!vidence
, , smoking, will creal 'e
,if,niYif;t
ho-.01,Ly for th,, fi0n.-iLry ,mong
and
iiL) 'ell'! 01, medical tind livalt.11
i thoriti.s (i ,11cluding thon". in
G-~rnn,lL 0-vice) will inflil'aice
Gov,_-!:,7.,i'u action against LILC
indu3try.
iv) Mo:ific-.tionr to the product will
have mcre credibility for Llic
crjr.:~ttn~,-_- if hLal.th authorities are
s,~- to have becit involved.
v) Ant.-i-c-noking resLrictionu, legal
or voluntary, will increase.
vi) Vol-.:ntaf-j concessionL; by the
in,~listry will riot prevent further
conc,~_rzions being domanded.
vii) Manar-ers in Companies, and
par-ic-ilarly No. is, will he
:~-.~!stionn aboul, the
and ~~calLli insue.
Z 116 0 t 0
To t:n(;ourage indtititry atLituden
.1 lich avoid jnLrallri .geflce,
Could pt-OV01:0 und!,:: i rabl
To L,.J, 1,~,biiel,y Lhe villidil.;
,I* -'tdcnee
vll(y .fllcli llece!.sitry to avoid
in law.,ojiLr or- to
corr-~L ot. di:;hollent
or 1;,, olq~nr,.,
iii) Not Lo enr:oltrage smoking
i. hy chi.ldr~!n
excen't;
iv) To delrty (indefinitely if
pon:~.ible) th(! iwponiLion of
i,nLraints or restrictions
on coupon trading
or pr..otioli.
-0 th." type,
V) To on:ure when pos!Able that all
B-A.T. Companies give similar
;1 riuwor,,, to que,-itious on smoking
iiod licalth.
PAGE 4
GUIDELINES
i.) Wherever possible, B-A.T.
Companies should seek to
exercise leaderLhip within
the Jndustry on Lho question
or smoking and health in thv
eo,v.Lry in hi.ll it opnrc,tion
and ,enk to influence Llie
industry to adopt Llie.B-A.T.
approach to the smoking and
huall;h issue.
ii) W,: Jwoulli e,,L,~v ii,Lo dialogne
wiLk medical authorities anti
Government departments on the
possibility of developing
modified products ncccptable
to the consumer and recommended
by medical authorities as b~:ing
likely to be less harmful.
iii) We should influence medical and
Government opinion and get each
group to accept some
renponsibility for helping to
solve what is seen to be a
major public health problem
rather than putting all the
onus on the industry.
vi) To discouragc zmy i-cpreFicritative
of Lhe tobacco industry appearing iv) We should
continue to persuade
on ra,lLo or television in medical and Government
opinion
connection with smoUng and that tobacco products
(modified
licalth unless the alter-native is as may from
time to time be
ev,-n more undnnival,le, in which required by
Government health
autherities as knowlidge increases)
car,i: 1-!te -~:o1ki'l "op
1 :3 : perrorm a useFul Pnd berieficial
-fe". social function.
CoNT/ ........


0
0
CL
0
0
SMOKING AND HEALTH PAGE
(D
ASSIMLITIONS POLICTES GUiDELrNus
B - RELMONS W1941 GOVERNMVINTS, MEDICAL
AUTHORITIES, 111D1jr3'1'RY AND Tim MEDI A (cont.)
viii) The tobacco indtintry will be better V)
Companies should be well informed
Plole to defend itselr from attack.-i an
Government attitudes to Gmoking
by opponents of omoking ir it and health,
forewarned and nlert
presents a united front. to likely Government
action, and
ix)
ill b
Th
lid
id knowledgeable about ministerial
0 ere w
e no va
ev
ence intentions and the influence and
that current cigarette advertising significance of
anti-smoking
03 increases total con:;umption. groups.
X) The extent to which competitors vi) Should
governments wish to control
will honour indijutry agreements the activities of
the tobacco
wil). drpend on its mitrket ,duirt, i~,duuLry by
legiolation, it would
be preferable for this to be
0 xi) There will be contintied efforLs by achieved
by the placing of tobacco
0 competitors to influence the under existing
multi-product
Industry Lowards a more aeUvc,-sivu consumer
protection 1,.-gislaLion
approa'.-h. rather than under a separnte
Tobacco Act. If tobacco were to
Cr be placed under ., Fee(] and Drug
law, classification of tobacco
under the food section would be
a- ceptable, but classification
of tobacco as a drug should be
avoided at all costs.
0
0 vii) Wat-ning noticen in ndvertl~in(,
hauld be razisted as lonj;
0 possible.
U
CD viii) If Governments insist on warning
notices on packs the wordinG
should make clear that it
emanates from a Government
source.
CONTI .........


0
0
CL
0
SMOKING AND i[BA111111 PAGE 6
CD
_h
0
ASSMPTIONS POLICIES GUr DELINES
0 B Rl"'LATTONS WITH GOVERNMENTS, KPDrCAL
AUTHORIVIFS, INDUSTI?Y Allf) q,11L, M1,J)I_A_
(coat.)
ix) To collect and disseminate
statistics and information to
CD Group tobacco companies on the
effect of advertising on-total
0 CiWette consumption.
03 X) Riblic Relations department at.
Hillbank will regularly review
and communicate to all concerned
"party line" answers to questions
most likely to arise. (Including
causntion and the possible
0 l,!9i31aLi-- of m.rij,,an.).
0
Cr
0
C)
r+
0
Cr
to
Co
to
Z 1 6) 0 10


0
0
CL
0
n
a
3
CD
0
CD
0
0
0
0
a
0
Cr
!D
CO
to
CO
ASSIMPHONS
TOBACCO AN11 ADDITIVES
C0113'1.n'~:-S Will continuo to exp,-CL
the industry to mitigate any
harmful effects its products
may have.
9 Z I Z60 I O~
SMOKING AND HEALTH
I) To (!1iminatc the use or tobacco i)
j~idtwd to be unsatisfactory
on microbiologic,11 o1, chemical
g--ounds.
ii) hot to permit any no. aoditive
in any product wilesr, it has
b,!en formally considered by the
A,I,Iitjv.s Guidan(~e Panel.
iii) To exclule any existing additives
if the.-c is reasonable evidence
OWL Okey are harmful.
PAGE
GUIDELINES
The Groupla normal internal
controls in addition to
statutory requirements on the
use of fumigants, should continue.


U0
0
0
CL
0
-3
0
0
0
%
U)
0
0
75)'
K)
to
0
0
f,41
0
Cr
to
ASSUMPTIMS
D TOBACCO SUBSTITUTES
i) The cheinieRl industry will
continue to take some
interest-, in tobacco substitutes.
ii) It is unlikely that 1.1tere will
be sufficient knowl(!(I(se and
medical advice availi~ble before
the end of 1975 Lo enable
positive action gui,tc-lines to
be issued in relation to tobacco
substitutes.
iii) It will not be possible to cont'irm
lasting consumer nct:(!ptance of
tob~iceo substitutes tintil they
have been on sale for at lenst
a year.
121Z6010(L-
SMOKING AND IFEALTH
POLMIrs
i) Not to use tobacco substitute
nlat~-rinls, or other n(,w
materials, in product.3 for
r, I'! tefore the constituents
0. sul:h materials have bt!en
Fully diucloscd by Lhe
supp.1 ie rs.
ii) Not; to use any tobacco
subsLituLe mateLial unless
Millbank is satisfied that it
has no disadvantages on health
iii) 1110 8L.",y changes in smoking
behaviour arising frow Lhe use
or 1.obacco substitute materials
when such mnLerials are odopted
for use in Products for sn1e.
i~) To :iI.-ly conuu cr aLt,ittidns to
- cigarettes containing tobacco
sizbstiLute material.
PAGE
GUIDELINES
j) B-A.T. will co-operate with
selected suppliers who are
developing substitute smoking
materinls.


0
0
CL
0
0
CD
0
CD
0
0
0
0
0
0
Cr
(D
:;MoKfl!:; AND MHALTH
PAGL
ASSIMPrIONG 110MCi ES GUIDELP-CS
E TAR Ai-J :.IICOPINE
':ic-,~-ine %,ill continue to be
i)
In co-operation with competitors,
1 ~y doctors to be B-A.T. will al-ays air, to ,,Pt
tar
c to tile majority
' and nicotine firmly separa' d
e
o 4
G. okers than tax. in the minds of the atithori
ties
V:
-re eventually be and, of tho public. Any
publinhed
_ tables should be compiled by a
p!:blic!!tion of tar ind
" litboratory independent of c,ny
lnf
ornii,ion in more me,1111u,- of the industry.
c,ui':,ies ,,!d publicution ey Publication of
brands in
also -4aclude the gan phase. alphabetical order is
preferable
inhilation nmoking will to ranking by levels.
JV:!,1iVihle 1"!nUll risku. ii) All Companies
should have
available at least one acceptable
brnnd which would be favaurably
placed in any letiGise table
tholirh not necensarily at the
bottow. A filter version of
a particular brand should always
show 11 loller tar and nicot-ine
level han the p Iain verEion.
iii) We should renist, as far as
possible, the imposition by
Government of inaximum levels for
tar v.Pd nicctine. if a Government
is deLer:ained to take such action
we chould strivo to have the levels
sufficiently hifth to cover
the majority of b.-E:nds on !he
71 arket. If necessary, we rl:ould
point out that a reduction of
r 4,-otina b~,lo,.,, a le,el sat' --"-,ct-
j
PIZIZ6010~


co
0 0 4.1
(D -0 0 0 -p 0
It 0 4. EA.. I.- I
P. V a 0,4. .,f .
0 00.
4 ~
a 0 7 .1 r.
8. .' , > C.- r-
13 r
CL14 0 4) M
0 ca .,0 4 0 0
Q. to
0
0 = 0 W W
V Q 0 0 4J bD ~~ .0 .0
r. CD
W) . ;4 = - ,
0 q 0 U b: C 16 rd r
0 -H 0 E; IM: 4~~
0 ..0
4- IJ
0 01 -,4) 1, 0 'S
010
10 0
L4
CD
.-0
BATCo document for Province of British Columbia 29
October 1999


0
0
CL
0
0
CD
0
0
0
0
0
rq-
0
Cr
(D
SMOKING AND HEALTH
POLICIFS
F GAS PILASE/CARBON MONOXIDE
i) Carbon monoxide will become is) To discourage
inhalable cigars. i)
increasingly regarded as a
serious health hazard for
smo%ors.
ii)
iii)
iv)
H, 1 Z60 1 U
PAGE 11
GUIDELINES
To reduce where possible the
carbon monoxide delivery of
cigarettes providing that this
does not increase the delivery
of other substances.
Product development wo rk on
reducing CO in cigarettes by
known means wi 11 continue.
Combustion studies will be
"OnLinued at Southampton in an
attempt to control both CO
and polycyclic aromatics.
At the R & D level we should be
prepared with products to meet
a gas phase league table
situation.


0
0
CL
0
M
0
CD
0
0
0
0
0
CT
CD
ASSUMPTIONS
G HEALTH CLAIMS
0 On leF,:,.,- grounds alone, it will
contin-ic to be to the industry's
advantage not to make explicit
health claims.
ii) The industry will make
inc-cusingly competitive use
of prod t6 I .or which healLh
ch'ims .111010 ift,plied.
z 6 0 10
SMOKING AND IfFAIT11
POLICTE3
i) Not to ;n3ke explicit health
ii) To discotivage unsupportable
11 caLL11 cljims fl-om any source.
PArr 12
GUIDELINES
i) To seek the agreement of the
industry and suppliers or tobacco
substitute and other materials
(including additives and filters)
not to make health claims for
their products.


0
0
CL
0
0
_h
0
M
0
C)
CD
0
L
0
0
0
0
Cr
CD
Z 6 0 10
SMOUNG ANT)'IIFATTir
GLOSSARY
1. Pasnive Smoking is tile involuntary inhal.Lion
by non-smokers mok r -de t e or
exhaled mainstream smoke. e s' si a r am
2. Sidestream Smoke is tile smoke rising from the
burning end of the cigarette when
smouldering.
3. Microbiolory is the)study of' the behaviour of
all forms of micro-organism (bacteria,
fungi, microbes etc
'I. Prychopharmacolonical - Lite effect.-; oil
hoUt mind and body of a particular agent
(e.g. alcohol).
BatrInke is a nmokiiii- material developed iii
G.R.D.C., Southumptoii, which incorporates
a number of inerL materiult; which can z-(,- ason
&IA y be supposed not to add to the toxicity
of tile smoka.
6. The S:jscepti))I.o 'Aib Group Hypothesis
arf-,Iios thal. cerl-ain small Groups or people
are
(p.rhap:l foi- gonel,it. 'Tio-re A s-iuk from Lhan
LliL- Inilk of Lite
population.
7. The Specific Activity of cif-irette smoko or of
smoke condensate is a measure or the
toxic dzmal-,c., effect;(!(] by iiiiii, -tight
(u:;tj;illy onti ov une milligriuu) of smoke,
in an appropriate biological system.
CONT/


0
0
CL
0
M
I
0
CD
0
0
0
Cr
0
0
rq~
0
Cr
CD
16 0 0
SMOKING AND IFEAPP11
GTOSSARY
...... /CONT
7. For example, consider two different typeL of
cigarette, A & B.
TPM Delivery 20 mg. 10 mg.
Specific acitivity
(per mg. of '11PM) It uni ts 12 units
Tito overall effect is given by mijItiplying tile
damage done by one mg. (4 or 12
units of kollage), by tile number of' mg.
OtAivuvcd.
Thus, for A, off,.-ef = 20 x 11 = 80 units
and, for B, effort = 10 x 12 = 120 units
Tile lower delivery cigarette is therefore the
more harmful, because it delivers
a smoke which is inherently more active.
PAGE its